Back
Establishment Labs Holdings Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
52
ESTA
Establishment Labs Holdings
Last Price:
47.79
Seasonality Move:
29.2%
Sell
43
BMY
Bristol-Myers Squibb
Last Price:
55.94
Seasonality Move:
1.69%
Buy
52
Establishment Labs Holdings (ESTA)
is a Buy
Is Establishment Labs Holdings a Buy, Sell or Hold?
- The current Establishment Labs Holdings [ESTA] share price is $46.76. The Score for ESTA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ESTA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $55.45. The Score for BMY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESTA Stock Price Chart
What is Establishment Labs Holdings's stock price today?
-
The Establishment Labs Holdings share price today is $46.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESTA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $55.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 59.26 | Buy |
| Chaikin Money Flow: | 201591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.32 - 45.4) | Buy |
| Bollinger Bands (100): | (40.87 - 46.17) | Buy |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 63.78 | Buy |
| Chaikin Money Flow: | 6017710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.14 - 54.1) | Buy |
| Bollinger Bands (100): | (43.28 - 52.28) | Buy |
ESTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.93 | Buy |
| 20-day SMA: | 43.43 | Buy |
| 50-day SMA: | 43.28 | Buy |
| 200-day SMA: | 45.51 | Buy |
| 8-day EMA: | 44.92 | Buy |
| 20-day EMA: | 43.99 | Buy |
| 50-day EMA: | 43.57 | Buy |
| 200-day EMA: | 44.91 | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.52 | Buy |
| 20-day SMA: | 53.07 | Buy |
| 50-day SMA: | 51.27 | Buy |
| 200-day SMA: | 47.96 | Buy |
| 8-day EMA: | 53.96 | Buy |
| 20-day EMA: | 53.1 | Buy |
| 50-day EMA: | 51.36 | Buy |
| 200-day EMA: | 49.82 | Buy |
Establishment Labs Holdings Earnings Growth & ESTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $0.98 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.54 per share, and an increase next year of $6.19 per share.
Establishment Labs Holdings Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||